# A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis

> **NCT00352755** · PHASE2 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 18 (actual)

## Conditions studied

- Peritoneal Neoplasms

## Interventions

- **PROCEDURE:** Surgical debulking with peritonectomy
- **DRUG:** Intraperitoneal 5FU
- **DRUG:** FOLFOX

## Key facts

- **NCT ID:** NCT00352755
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** after interim analysis it was determined that the risks were too great in comparision to the results
- **Last updated:** 2016-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00352755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00352755, "A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00352755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*